Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$48.09 - $57.79 $1.26 Million - $1.51 Million
-26,107 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$47.19 - $62.68 $655,563 - $870,750
-13,892 Reduced 34.73%
26,107 $1.37 Million
Q3 2021

Nov 15, 2021

SELL
$56.91 - $67.81 $35,227 - $41,974
-619 Reduced 1.52%
39,999 $2.39 Million
Q2 2021

Aug 12, 2021

BUY
$64.02 - $71.72 $225,606 - $252,741
3,524 Added 9.5%
40,618 $2.75 Million
Q1 2021

May 05, 2021

BUY
$53.26 - $68.08 $417,079 - $533,134
7,831 Added 26.76%
37,094 $2.43 Million
Q4 2020

Feb 12, 2021

SELL
$43.41 - $56.51 $602,443 - $784,245
-13,878 Reduced 32.17%
29,263 $1.65 Million
Q3 2020

Nov 12, 2020

BUY
$47.43 - $60.75 $175,917 - $225,321
3,709 Added 9.41%
43,141 $2.1 Million
Q2 2020

Aug 11, 2020

BUY
$43.51 - $66.59 $418,827 - $640,995
9,626 Added 32.3%
39,432 $2.2 Million
Q1 2020

Apr 27, 2020

BUY
$32.82 - $81.13 $49,295 - $121,857
1,502 Added 5.31%
29,806 $1.51 Million
Q4 2019

Feb 10, 2020

SELL
$60.96 - $77.7 $15,118 - $19,269
-248 Reduced 0.87%
28,304 $2.19 Million
Q3 2019

Nov 12, 2019

BUY
$55.78 - $68.08 $132,310 - $161,485
2,372 Added 9.06%
28,552 $1.81 Million
Q2 2019

Aug 12, 2019

SELL
$53.69 - $65.47 $1.41 Million - $1.72 Million
-26,303 Reduced 50.12%
26,180 $1.53 Million
Q1 2019

May 15, 2019

SELL
$44.53 - $58.9 $184,621 - $244,199
-4,146 Reduced 7.32%
52,483 $2.98 Million
Q4 2018

Feb 13, 2019

SELL
$47.64 - $71.26 $428,188 - $640,484
-8,988 Reduced 13.7%
56,629 $2.81 Million
Q3 2018

Nov 13, 2018

SELL
$52.03 - $71.41 $151,199 - $207,517
-2,906 Reduced 4.24%
65,617 $4.66 Million
Q2 2018

Aug 14, 2018

BUY
$48.15 - $56.68 $1.41 Million - $1.66 Million
29,264 Added 74.54%
68,523 $0
Q1 2018

May 10, 2018

BUY
$46.03 - $61.28 $1.81 Million - $2.41 Million
39,259 New
39,259 $2.05 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.